secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001493152-26-021231
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical's LIBERTY robotic system adopted by multiple accounts, including pivotal trial sites
--------------------------------------------------------------------------------

- LIBERTY Endovascular Robotic System won accounts in key U.S. territories, including two ACCESS-PVI trial sites.
- Company to attend GEST conference in NYC from May 14-17, 2026 to expand commercial footprint.
- Alon Tamir appointed VP of Sales, EMEA to lead international commercialization.
- CEO cites 'strong tailwind post SIR' and expects sustained momentum through peer-to-peer communication.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226021231/0001493152-26-021231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226021231/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer